OncoMatch/Clinical Trials/Blood Cancer — Myeloproliferative (MPN)
Blood Cancer — Myeloproliferative (MPN) Clinical Trials
OncoMatch filters Blood Cancer — Myeloproliferative (MPN) trials by the molecular markers that determine eligibility — JAK2, CALR, MPL, ASXL1, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Blood Cancer — Myeloproliferative (MPN) trials
These are the molecular markers most commonly required or evaluated in Blood Cancer — Myeloproliferative (MPN) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Blood Cancer — Myeloproliferative (MPN) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Italfarmaco
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Celgene
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Merck Sharp & Dohme LLC
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
PharmaEssentia Japan K.K.
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
University of Birmingham
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
University Hospital, Brest
How OncoMatch finds Blood Cancer — Myeloproliferative (MPN) trials for you
AI reads the protocol
Every Blood Cancer — Myeloproliferative (MPN) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Blood Cancer — Myeloproliferative (MPN) and mark your biomarker results — JAK2, CALR, MPL — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.